UBS Maintains Neutral on Xponential Fitness, Lowers Price Target to $4.5
UBS analyst Arpine Kocharyan maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $7 to $4.5.
Stocks · News reference
Xponential Fitness Lowers FY2026 Sales Guidance from $260.000M-$270.000M to $250.000M-$260.000M vs $263.631M Est
Xponential Fitness (NYSE:XPOF) lowers FY2026 sales outlook from $260.000 million-$270.000 million to $250.000 million-$260.000 million vs $263.631 million estimate.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Xponential Fitness Names Jennifer Ryu As Chief Financial Officer, Effective As Of October 19, 2026
8-K filing — Xponential Fitness, Inc. (XPOF)
Filed: 2026-09-08 AccNo: 0001193125-26-385205 Size: 202 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Roth Capital Maintains Neutral on Xponential Fitness, Lowers Price Target to $5
Roth Capital analyst George Kelly maintains Xponential Fitness (NYSE:XPOF) with a Neutral and lowers the price target from $7 to $5.